최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Tuberculosis and respiratory diseases : TRD = 결핵 및 호흡기 질환, v.63 no.3 = no.272, 2007년, pp.251 - 260
신종욱 (중앙대학교 의과대학 내과학교실) , 이수환 (중앙대학교 의과대학 병리학교실) , 박언섭 (중앙대학교 의과대학 병리학교실)
Purpose: An imbalance of cell proliferation and cell apoptosis is an important mechanism in carcinogenesis. Capase 3, survivin and p53 have been identified as important members of the apoptotic related proteins. This study evaluated the proliferating cell nuclear antigen(PCNA), apoptosis, apoptotic ...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Zang EA, Wynder AL. Cumulative tar exposure. A new index fm- estimating lung cancer lisk among cigarette smokers. Cancer 1992;70:69-76
Foley JF, Anderson MW, Stoner GD, Gaul DW, Hardisty JF, Maronpot RR. Proliferative lesions of the mouse lung: progression studies in strain A mice. Exp Lung Res 1991;17:157-68
Malkinson AM. Pulmonary lung tumors in mice: an experimentally manipulable model of human adeno-carcinoma. Cancer Res 1992;52:2670s-6s
Re FC, Manenti G, Borrello MG, CAllomho MP, Fisher JH, Flerotti MA, et al. Multiple molecular alterations in mouse lung tumors. Mol Carcinog 1992;5:155-60
Robbins BA, Kastan MB. Cell cycle control and cancer. Science 1994;266:1821-8
Robbins DA, Vega D, Ogata K, Tan EM, Nakamura RM. Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies. Arch Pathol Lab Med 1987;111:841-5
Cox LB. Multiple pathwoys control cell gmwth and transformation: overlapping and independent activities of p63 and p21. J Pathol 1997;183:134-40
Grossman D, McNiff JM, Li F, Altieli OC. Expr'ESsion and targeting of the apoptosis inhibitor, survivin, in human melanoma. J Invest Dennatol 1939;113:1076-81
Gavneli Y, Sherman Y, Ben-Sasson SA. Identification of progammed cell death in situ via specific laheling of nuclear DNA fragmentation. J Cell Biol 1992; 119:493-601
Altieli OC, Marchisio C. Survivin apoptosis: an interloper between cell death and cell proliferation in cancer. Lnb Invest 1939;79:1327-33
Alnenui ES, Livinston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, et al. Human ICE/CED-3 protease nomenclature. Cell 1996;87:171
Mirza A, McGuirk M, Hockenberry, Wu Q, Ashar H, Black S, et al. Human survivin is negatively regulated by wild-type p53 and participates in p53 dependent apoptotlc pathway. Onmgene 2002;21:2613-22
Chung JH, Jang JJ, Lee MI, Ham EK. Altered retinoblastoma protein expression and proliferative activity in urethane induced mouse lung tumori-genesis. Cancer Res Treat 2002;34:258-63
Bravo R, Frank R, Blundell PA, Macdonald-Bravo H Cyclin/PCNA is the auxillary proteins of DNA polymerase-delta. Nature 1987;326:615-7
Morris GF, Mathews MB. Regulation of proliferating cell nuclear antigen during the cell cycle. J Biol Chem 1989;264: 13866-64
Kelman Z. PCNA: structure, functions and interactions. Oncogene 1997;14:629-40
Tormanen D, Eerola AK, Rainio P, Vahakangas K, Soini Y, Sormunen R, et al. Enbanoed apoptosis predicts shortened survival in non-small cell lung carcinoma. Cancer Res 1996;55:6596-602
Lipponen PK, Aaltomaa S. Apoptosis in bladder cancer as related to standard prognostic factors and prognosis. J Pathol 1994;173:333-9
Shibata MA, Maroulakou IG, Jorcyk CL, Gold LG, Ward JM, Green JE. p53 independent apoptosis during mammary tumor progression in C(3)/SV 40 large T antigen transgenic mice; Supression of apoptosis during the transition from preneoplasia to carcinoma. Cancer Res 1996;56:2998-3003
Sola B. Survivin: anti-apoptosis proteins and a prognostic markers for progression and recurrence. Harefuah 2002; 141: 103-7
Ito T, Shiraki K, Sugimoto K, Yamanaka T, Fujikawa K, Ito m, et al. Survivin promotors cell proliferation in human hepatocellular carcinoma. Hepatology 2000;31:1080-5
Lin LJ, Zheng CQ, Jin Y, Ma Y, Jiang WG, Ma T. Expression of survivin protein in human colorectal carcinogenesis. World J Gastroenlerol 2003;9:974-7
Zhang X, Dong N, Yin L, Cal N, Ma H, You J, et al. Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues. J Med Virol 2005; 77:374-81
Akyumk N, Memis L, Elcinci O, Kokturk N, Ozturk C. Survivin expressIon in pre-invaSIve lesions and non-small cell lung carcincma. Virchows Arch 2006;449:164-70
Hsia JY, Chen CY, Chen JT, Hsu CP, Shai SE, Yang SS, et al. Prognostic significance of caspase-3 expression in primary resected esophageal squamous cell carcinoma. Eur J Surg Oncol 2003;29:44-8
Li YH, Wang C, Meng K, Chen LB, Zhou XJ, Influence of survivin and caspase-3 on cell apoptosis and prognosis in gastric carcinoma. World J Gastroenterol 2004; 10: 1984-8
Isobe N, Onadem H, Mori A, Shimada Y, Yang W, Yasuda S, et al. Caspase-3 expression in human gastric carcinoma and its clinical significance. Oncology 2004;66:201-9
Hall PA, Lane DP. p53 in tumor pathology: can we trust immunohistochemistry? J Pathol 1994;172:1-4
Cazorla M, Hernandez L, Pernandez PL, Pabra A, Peinado MA, Dasenbrock C, et al. Ki-ras gene mutations and absence of p63 gene mutations in spontaneous and urethane-induced early lung lesions in CBA/J mice. Mol Carcinog 1993;21:261-60
Horio Y, Chen A, Rice P, Roth JA, Malkinson AM, Schrump DS. Ki-ms and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice. Mol Cacinog 1996;17:217-23
Ohno J, Horio Y, Sekido Y, Hasegawa Y, Takahashi M, Nishizawa J, et al. Telomerase activation and p53 mutations in urethane-induced A/J mouse lung tumor development. Carcinogenesis 2001;22:761-6
Mori I, Yasuhara K, Hayashi SM, Nonoyama T, Nomura T, Yanai T, et al. Aberrant expression of cyclin Dl in pulmonary proliferative lesions induced by high doses of urethane in transgenic mice carrying the human prototype c-H-ras gene. J Vet Med Sci 2001;63:261-8
※ AI-Helper는 부적절한 답변을 할 수 있습니다.